Repligen
RGEN
#2404
Rank
C$10.97 B
Marketcap
C$194.55
Share price
-6.81%
Change (1 day)
14.33%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: C$10.97 Billion

As of June 2026 Repligen has a market cap of C$10.97 Billion. This makes Repligen the world's 2404th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$10.97 B-14.35%
2025C$12.81 B9.5%
2024C$11.70 B-12.12%
2023C$13.31 B4.38%
2022C$12.75 B-31.64%
2021C$18.66 B39.58%
2020C$13.36 B112.5%
2019C$6.29 B99.41%
2018C$3.15 B58.78%
2017C$1.98 B41.81%
2016C$1.40 B8.37%
2015C$1.29 B71.7%
2014C$0.75 B62.46%
2013C$0.46 B137.95%
2012C$0.19 B79.69%
2011C$0.10 B-24.89%
2010C$0.14 B8.5%
2009C$0.13 B-7.18%
2008C$0.14 B-29.37%
2007C$0.20 B104.12%
2006C$99.41 M-29.11%
2005C$0.14 B34.8%
2004C$0.10 B-38.7%
2003C$0.16 B29.29%
2002C$0.13 B26.96%
2001C$0.10 B-23.09%
2000C$0.13 B33.61%
1999C$0.10 B183.76%
1998C$35.45 M76.5%
1997C$20.08 M-22.37%
1996C$25.87 M

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Repligen was reported to be:

C$11.77 Billion
by Nasdaq info icon info icon
C$11.77 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$197.36 B 1,698.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$267.16 B 2,334.53%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$554.24 B 4,950.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$169.77 B 1,447.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$29.41 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$2.18 B-80.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$24.27 B 121.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$15.68 B 42.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.82 B 44.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$15.43 B 40.62%๐Ÿ‡บ๐Ÿ‡ธ USA